We are excited to share that our client, Ichor Therapeutics, Inc., a LaFayette, NY-based pre-clinical biotechnology clinical research organization, has been nominated and selected by Centerstate CEO for their outstanding achievements during the past year. Centerstate CEO, the economic development and chamber of commerce of Greater Syracuse, New York, annually selects outstanding regional businesses for their contribution to the region’s economic growth and prosperity. “We feel very privileged for being selected as a finalist,” remarked Kelsey Moody, CEO at Ichor Therapeutics. “This recognition is a testament to the dedication of Ichor’s growing research team, who have surpassed my highest aspirations for what can be achieved in drug discovery and early drug development.”
One of our specialties at Newman & Lickstein, LLP is helping life science & biotechnology professionals navigate through the pivotal moments of their corporate lifecycle to achieve their most critical business and legal goals.
